Learn More
Waters Corp UPLC Therapeutic Peptide Method Development Kit
Supplier: Waters Corp 176001835
The UPLC Therapeutic Peptide Method Development kit simplifies the process of sample preparation and LC method development for the analysis of therapeutic peptides in plasma. The kit contains one 96-well Oasis Peptide μElution Method Development Plate (186004713), one ACQUITY UPLC 1.7 µm BEH 300 C18 reversed-phase 2.1x50 mm column (186003685), three 96-well 1 mL collection plates and cap mats (600001043), and a detailed screening protocol.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.